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Abstract
Objectives: To examine alcohol consumption in relation to prostate cancer incidence in the Netherlands Cohort
Study.
Methods: At baseline in 1986, 58,279 men aged 55–69 years completed a self-administered questionnaire on diet,
consumption of alcoholic beverages and other risk factors for cancer. For data processing and analyses the case–
cohort approach was used. After 6.3 years of follow-up, 680 incident primary prostate cancer cases were available
for analysis.
Results: In multivariate analyses adjusted for age, socioeconomic status and family history of prostate cancer, no
association between total alcohol consumption, alcohol intake from beer and liquor and prostate cancer risk was
found. Increased associations were found for alcohol from white wine and fortified wines compared to nondrinkers,
but not for red wine. The RRs (95% CI) in the intake category of P15 g/day were 3.3 (1.2–9.2) and 2.3 (1.2–4.7),
respectively, after additional adjustment for total alcohol intake. There was, however, no significant trend in risk.
Alcohol intake was more strongly related with localized than with advanced prostate tumors.
Conclusion: Our results do not support an important role for alcohol in prostate cancer etiology. Nevertheless, for
specific types of alcoholic beverages, particularly wines, a positive association was suggested which needs
examination in further studies.
Introduction
Not much attention is given to alcohol consumption as a
potential risk factor for prostate cancer in most reviews
on this disease [1–5]. Nevertheless, when we searched the
literature we found at least 14 cohort studies [6–19] and
23 case–control studies [20–42] in which alcohol con-
sumption in relation to prostate cancer risk was inves-
tigated. In the majority of these studies, however, no
extensive evaluation was made. For example, there were
four cohort studies [6, 10, 13, 14] and 10 case–control
studies [21, 22, 25–27, 33, 36, 38, 40, 41] in which some
data on dierent types of alcoholic beverages were
presented. In some studies it was suggested that alcohol
consumption might be associated with prostate cancer
etiology [11, 13, 14, 21, 22, 25, 26, 36, 40]. There were
only three studies in which alcohol consumption was
investigated in subgroups of aggressive or advanced
prostate tumors [21, 25, 27]. Therefore, data on the
hypothesis that environmental factors might be more
strongly related to advanced prostate cancer are still
sparse in regards to consumption of alcohol. We further
investigated this relationship in the Netherlands Cohort
Study (NLCS) on diet and cancer.
Materials and methods
The cohort
The study design has been described elsewhere [43]. In
brief, the NLCS was initiated in September 1986. The
Cancer Causes and Control 10: 597–605, 1999. 597Ó 1999 Kluwer Academic Publishers. Printed in the Netherlands.
male cohort consists of 58,279 men who completed the
questionnaire on usual diet, alcohol consumption,
personal and family history of cancer, other risk factors
for cancer, and demographic data. The case–cohort
approach [44] was used for data processing and analysis:
for calculation of cancer incidence rates, the number of
cancer cases for the entire cohort was used as the
numerator, while person-years at risk were estimated
using a random male subcohort sample, which was
sampled directly after identification of the total cohort.
The male subcohort includes 1688 men. Follow-up for
incidence of prostate cancer was established by com-
puterized record linkage with all nine cancer registries in
The Netherlands, and with the Dutch national database
of pathology reports (PALGA) [45]. The subcohort has
been followed up biennially for vital status information.
Completeness of follow-up of cancer was at least 96%
[46] and no subcohort members were lost to follow-up.
After a follow-up period of 6.3 years (September 1986–
December 1992), 704 incident, microscopically or histo-
logically confirmed, primary prostate cancer cases were
detected.
The questionnaire
The self-administered questionnaire has been described
elsewhere [47]. Briefly, usual consumption of food and
beverages during the year preceding the start of the
study was assessed with a 150-item semiquantitative
food-frequency questionnaire. Participants were asked
to report their frequency of consumption of beer, red
wine, white wine, sherry and other fortified wines,
liqueurs and liquor (e.g. Dutch gin, brandy and whis-
key). Categories ranged from ‘‘never or less than once
per month’’ to ‘‘6–7 days per week’’ and information on
the number of glasses drunk per consumption day was
also requested. Daily alcohol consumption (ethanol in
g/day) was calculated using the computerized Dutch
food composition table [48]. The ethanol contents (per
100 g) used were: 4 g for beer, 10 g for red and white
wine, 14 g for fortified wines, 17 g for liqueurs, and 29 g
for liquor. The questionnaire has been validated against
a 9-day diet record; the Spearman correlation coecient
for alcoholic beverages was 0.89 for all subjects and 0.85
for users of alcoholic beverages [47].
Data analysis
Questionnaire data were key-entered twice and pro-
cessed for all incident cases in the cohort and for all
subcohort members in a manner blinded with respect to
case/subcohort status. This was done in order to
minimize observer bias in coding and interpretation of
the data. After excluding prevalent cancer cases other
than skin cancer from the subcohort, 1630 men re-
mained for analysis. Furthermore, subjects with incom-
plete alcohol data were also excluded. Alcohol data were
considered incomplete when all questions on consump-
tion frequency of alcoholic beverages were left blank
and two questions on alcohol consumption pattern did
not indicate that the subject was a nondrinker. These
two questions concerned alcohol intake during the past
week and 5 years previously [49, 50]. The results
presented here are based on 680 incident prostate cancer
cases and 1591 subcohort members for whom alcohol
data were considered complete.
The associations between alcohol consumption and
some potential confounding factors for prostate cancer
were evaluated among men in the subcohort, by
comparing the proportion of men with these risk factors
across categories of alcohol consumption. Variables that
were considered as potential confounders were age,
prostate cancer in first-degree relatives (father and
brothers), and socioeconomic status. Because in pre-
vious analyses no associations were observed between
total vegetable and fruit consumption [51] and total
energy and fat intake and prostate cancer risk [52], these
factors were not considered as confounding factors.
Rate ratios (RRs) and 95% confidence intervals (95%
CI) were computed using the GLIM statistical package
[53]. Exponentially distributed survival times were
assumed in the follow-up period. Since standard soft-
ware was not available, specific macros were developed
to account for the additional variance introduced by
using the subcohort instead of the entire cohort [54].
Tests for trend were based on likelihood ratio tests and
two-sided p-values are used throughout this report.
Age-adjusted as well as multivariate-adjusted analyses
were done for both categorized and continuous vari-
ables; in addition to the above-mentioned confounding
factors, alcohol intake from specific types of alcoholic
beverages was also adjusted for total alcohol intake.
Cases detected during the first 2 years of follow-up were
additionally excluded from analyses to evaluate whether
preclinical symptoms might have influenced results.
Analyses were also done in case subgroups of localized
(T0–2, M0) and advanced (T3–4, M0; T0–4, M1)
prostate tumors.
Results
The percentages of nondrinkers were 15.5 and 16.2,
respectively, for subcohort members and cases. Among
drinking men the mean total alcohol intake (SD) was
17.1 (16.6) g/day for subcohort members and 17.7 (15.9)
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g/day for prostate cancer cases. Data on the association
between alcohol consumption and some potential con-
founding factors among subcohort members are shown
in Table 1. The proportion of older men was somewhat
higher among nondrinkers compared to drinkers. Non-
drinkers less often had a positive family history of
prostate cancer and more often had a lower socio-
economic status than drinkers.
In Table 2, rate ratios of prostate cancer for both
categorized and continuous variables of alcohol intake
are shown. Total alcohol consumption was not related
to prostate cancer risk in the NLCS. For men consum-
ing 30 g alcohol per day or more the RR was 1.1 (95%
CI: 0.8–1.6) compared to men who are nondrinkers.
There was also no trend in risk. The RR for intake of
alcohol from beer was decreased in the highest intake
category (RR for P30 g/day vs. nondrinkers was 0.5,
95% CI: 0.2–1.3). In intermediate categories no associ-
ations were noted. For alcohol from liquor, no clear
associations with prostate cancer risk were observed.
For intake of alcohol from wine, a borderline significant
increased risk was found for the highest vs. the lowest
intake category (RR = 2.3, 95% CI: 1.0–5.3). In the
intermediate-intake categories no increased risk was
observed. The RR for the continuous variable was 1.1
(95% CI: 1.0–1.3) per 10 g increment.
In Table 3, alcohol intake is evaluated separately for
dierent types of wine: red wine, white wine, fortified
wines and liqueurs. Because of sparse data, the highest
intake category comprised men consuming 15 g alcohol
or more. For liqueurs there were only two exposure
categories. No associations with risk of prostate cancer
were found for intake of alcohol from red wine and
liqueurs. For intake of alcohol from white wine, an
increased risk was observed with higher consumption,
but only in the highest intake category (RR = 3.3, 95%
CI: 1.2–9.2). Also for intake of alcohol from fortified
wines, only in the highest intake category was an
increased risk found (RR = 2.3, 95% CI: 1.2–4.7) and
no dose–response relationship was observed. The results
shown in Tables 2 and 3 did not materially change
after exclusion of cases detected in the first 2 years of
follow-up (data not shown).
Alcohol intake was also evaluated in subgroups of
localized and advanced prostate tumors and the results
are shown in Table 4. The two highest categories of
alcohol from beer (15–29 and P30 g/day) were com-
bined to allow for a reasonable number of cases in the
subgroup analyses. Furthermore, because the eect of
alcohol from white wine and alcohol from fortified
wines was similar in the overall analysis, these two
sources of alcohol intake were combined in order to
attain a reasonable number of cases. The number of
cases for alcohol from liqueurs was not sucient to
conduct meaningful subgroup analyses. Overall, alcohol
intake showed stronger associations with localized
prostate tumors than with advanced prostate tumors.
In the subgroup of localized prostate tumors, all RRs
for total alcohol intake were above the null value, but
only in the intake category of 0.1–4.9 g/day was a
borderline significantly increased risk found
(RR = 1.7, 95% CI: 1.0–2.6). No associations with
advanced prostate tumors were found. Alcohol from
beer showed no clear associations with risk of either
Table 1. Distribution of potential confounding factors for prostate cancer in male subcohort members with complete alcohol consumption data,
Netherlands Cohort Study, 6.3 years of follow-up (1986–92)
Potential confounding variable Percentage with risk factor
Nondrinkers (n = 246) Drinkers
<15 g/day (n = 767) P 15 g/day (n=578)
Age (years)
55–59 32.9 40.2 37.5
60–64 31.7 34.6 36.0
65–69 35.4 25.3 26.5
Family history of prostate cancer
No 98.8 96.9 97.6
Yes 1.2 3.1 2.4
Socioeconomic status1
Low 55.7 50.4 43.5
Medium 32.4 34.5 33.7
High 11.9 15.1 22.8
1 Low is defined as primary school with/without lower vocational education, medium as secondary school or medium level vocational
education, high as university or higher-level vocational education.
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localized or advanced prostate tumors. For alcohol
from wine, all RRs were increased in the subgroup of
localized prostate tumors. Subjects consuming P30 g
alcohol per day from wine had a RR of 4.6 (95% CI:
1.6–13.4) compared to nondrinkers. Among advanced
prostate tumors, only the RR in the highest intake
category was increased (RR = 2.9, 95% CI: 1.0–8.5).
In both subgroups, however, no trend in risk was
observed. Although all RRs were increased for intake of
alcohol from liquor in the localized prostate tumors
subgroup, only one RR was statistically significant
and a dose–response relationship was not observed
(p-trend = 0.08). For advanced prostate tumors, no
associations with intake of alcohol from liquor were
apparent. No trend in risk was found for intake of
alcohol from red wine in both subgroups. A borderline
significant positive trend in risk was observed for the
combined intake of alcohol from white wine and
fortified wines among localized prostate tumors (p-
trend = 0.06). Compared to nondrinkers, men with an
intake of P15 g/day had a RR of 3.6 (95% CI: 1.5–8.4).
Among the advanced prostate tumor group, the
eect estimate for the same contrast was 2.2 (95% CI:
1.0–5.2).
Table 2. Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer according to intake of alcohol, Netherlands Cohort
Study, 6.3 years of follow-up (1986–92)
Alcohol intake (g/day) Age-adjusted Multivariate adjusted1
No. of cases/person-years
in subcohort
RR (95% CI) No. of cases/person-years
in subcohort
RR (95% CI)
Nondrinkers2 110/1440 1.00 109/1428 1.00
Total alcohol3
0.1–4 143/1947 1.1 (0.8–1.5) 143/1931 1.1 (0.8–1.5)
5–14 161/2637 1.0 (0.7–1.3) 161/2624 0.9 (0.7–1.3)
15–29 162/2181 1.1 (0.8–1.5) 161/2162 1.1 (0.8–1.4)
P 30 104/1324 1.2 (0.9–1.7) 101/1324 1.1 (0.8–1.6)
p-trend 0.37 p-trend 0.74
Continuous, 10 g increment 1.0 (1.0–1.1) 1.0 (1.0–1.1)
Alcohol from beer
No beer 213/2621 1.1 (0.8–1.5) 212/2608 1.1 (0.8–1.5)
0.1–4 220/3376 1.0 (0.8–1.3) 218/3341 0.9 (0.7–1.3)
5–14 112/1594 1.2 (0.8–1.6) 111/1594 1.1 (0.7–1.6)
15–29 19/329 1.1 (0.6–2.0) 19/329 1.0 (0.5–2.0)
P 30 6/170 0.5 (0.2–1.3) 6/170 0.5 (0.2–1.3)
p-trend 0.76 p-trend 0.48
Continuous, 10 g increment 0.9 (0.8–1.1) 0.9 (0.8–1.1)
Alcohol from wine
No wine 220/3273 1.0 (0.8–1.4) 219/3239 1.1 (0.8–1.5)
0.1–4 199/2685 1.1 (0.8–1.5) 198/2679 1.1 (0.8–1.4)
5–14 91/1421 1.0 (0.7–1.4) 90/1415 0.9 (0.6–1.4)
15–29 40/575 1.2 (0.7–1.8) 39/575 1.1 (0.7–1.8)
P 30 20/135 2.3 (1.2–4.7) 20/135 2.3 (1.0–5.3)
p-trend 0.12 p-trend 0.67
Continuous, 10 g increment 1.1 (1.0–1.3) 1.1 (1.0–1.3)
Alcohol from liquor
No liquor 172/2616 1.1 (0.8–1.5) 172/2597 1.1 (0.8–1.5)
0.1–4 155/2211 1.1 (0.8–1.4) 154/2208 1.0 (0.7–1.4)
5–14 109/1595 1.0 (0.7–1.4) 109/1589 1.0 (0.7–1.4)
15–29 94/1149 1.1 (0.8–1.5) 92/1130 1.1 (0.7–1.6)
P 30 40/518 1.2 (0.7–1.9) 39/518 1.1 (0.6–2.0)
p-trend 0.65 p-trend 0.96
Continuous, 10 g increment 1.0 (0.9–1.1) 1.0 (0.9–1.1)
1 Adjusted for age, family history of prostate cancer, socioeconomic status, and total alcohol intake.
2 Reference category.
3 Not adjusted for total alcohol intake.
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Discussion
In this study, we found no evidence that total alcohol
consumption is related to the risk of developing prostate
cancer. However, when specific types of alcohol were
investigated, high intakes of alcohol from white wine
and fortified wines were associated with increased risks.
No clear associations existed between alcohol intake
from beer, liquor, red wine, and liqueurs and prostate
cancer risk. We found no evidence that consumption of
alcohol is more related to advanced prostate tumors. On
the contrary, alcohol intake showed mostly positive
associations in the subgroup of localized prostate
tumors.
An important strength of our study is the prospective
design; therefore, recall bias is unlikely. Furthermore,
selection bias due to loss to follow-up did not influence
our results because of the high completeness of follow-
up of cases and subcohort members in the NLCS [46,
55]. Another advantage is that the assessment of alcohol
consumption in the NLCS allowed us to extensively
evaluate a possible association with prostate cancer risk.
Not only overall consumption of alcohol, but also
dierent types of alcoholic beverages were investigated.
Moreover, consumption of several types of alcoholic
beverages was also evaluated within case subgroups
based on tumor characterization. Misclassification of
exposure is a possible limitation of our study. However,
if misclassification has occurred, this is expected to be
nondierential and risk estimates are most likely biased
towards the null value. Abstainers and ex-drinkers were
not separated in our study, but were included in our
reference category of nondrinkers. Ex-drinkers may
dier in prostate cancer risk from abstainers; therefore
Table 3. Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer according to intake of alcohol, Netherlands Cohort
Study, 6.3 years of follow-up (1986–92)
Alcohol intake (g/day) Age-adjusted Multivariate adjusted1
No. of cases/person-years
in subcohort
RR (95% CI) No. of cases/person-years
in subcohort
RR (95% CI)
Nondrinkers2 110/1440 1.00 109/1428 1.00
Alcohol from red wine
No red wine 349/5071 1.0 (0.8–1.4) 347/5030 1.0 (0.8–1.4)
0.1–4 151/2178 1.1 (0.8–1.4) 150/2178 1.0 (0.7–1.3)
5–14 55/602 1.4 (0.9–2.2) 54/596 1.3 (0.8–2.0)
P 15 15/239 1.0 (0.5–1.8) 15/239 0.8 (0.4–1.7)
p-trend 0.21 p-trend 1.00
Continuous, 5 g increment 1.0 (0.9–1.1) 1.0 (0.9–1.1)
Alcohol from white wine
No white wine 362/5274 1.1 (0.8–1.4) 359/5233 1.1 (0.8–1.4)
0.1–4 180/2551 1.1 (0.8–1.4) 180/2545 1.0 (0.7–1.4)
5–14 20/226 1.3 (0.7–2.3) 19/226 1.2 (0.6–2.2)
P 15 8/38 3.4 (1.4–8.5) 8/38 3.3 (1.2–9.2)
p-trend 0.13 p-trend 0.54
Continuous, 5 g increment 1.2 (1.0–1.5) 1.2 (1.0–1.5)
Alcohol from fortified wines
No fortified wines 411/5772 1.1 (0.8–1.4) 408/5731 1.1 (0.8–1.5)
0.1–4 108/1599 1.0 (0.7–1.4) 108/1593 0.9 (0.6–1.3)
5–14 27/557 0.7 (0.4–1.2) 26/557 0.7 (0.4–1.1)
P 15 24/161 2.5 (1.3–4.7) 24/161 2.3 (1.2–4.7)
p-trend 0.53 p-trend 0.77
Continuous, 5 g increment 1.1 (1.0–1.2) 1.1 (1.0–1.2)
Alcohol from liqueurs
No liqueurs 511/7313 1.1 (0.8–1.4) 507/7266 1.0 (0.8–1.3)
0.1–4 52/669 1.2 (0.8–1.8) 52/669 1.1 (0.7–1.7)
P 5 7/107 1.2 (0.5–3.0) 7/107 1.2 (0.5–3.0)
p-trend 0.37 p-trend 0.48
Continuous, 5 g increment 0.9 (0.6–1.4) 0.9 (0.6–1.5)
1 Adjusted for age, family history of prostate cancer, socioeconomic status, and total alcohol intake.
2 Reference category.
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our estimated risks might be biased in either direction.
Thus far, however, an association between alcohol and
prostate cancer has not been established definitely and it
is also not known whether or how the timing of alcohol
consumption might play a role. Further studies are
needed to evaluate this matter. We considered most of
the factors that have been implied in prostate cancer
etiology and factors showing an association with pros-
tate cancer risk in the NLCS were included into the
multivariate model. Thus, total energy and fat intake
were not included and also vegetable and fruit con-
sumption were not included. When multivariate anal-
yses were conducted with inclusion of the above-
mentioned factors, the rate ratios were not changed
Table 4. Rate ratios (RRs) and 95% confidence intervals (95% CI) for prostate cancer according to intake of alcohol, in subgroups of localized
and advanced prostate tumors, Netherlands Cohort Study, 6.3 years of follow-up (1986–92)
Alcohol intake
(g/day)
No. of person-years
in subcohort
Localized prostate tumors
(T0–2, M0) n = 247
Advanced prostate tumors
(T3–4, M0; T0–4, M1) n = 236
No. of cases RR (95% CI)1 No. of cases RR (95% CI)1
Nondrinkers2 1428 28 1.00 34 1.00
Total alcohol3
0.1–4 1931 59 1.7 (1.0–2.6) 44 1.0 (0.6–1.6)
5–14 2624 55 1.1 (0.7–1.8) 63 1.1 (0.7–1.6)
15–29 2162 61 1.4 (0.9–2.3) 49 0.9 (0.6–1.5)
P 30 1324 33 1.3 (0.8–2.2) 35 1.1 (0.7–1.8)
p-trend 0.67 p-trend 0.94
Alcohol from beer
No beer 2608 84 1.7 (1.1–2.8) 63 1.0 (0.6–1.6)
0.1–4 3341 82 1.4 (0.9–2.3) 81 1.1 (0.7–1.7)
5–14 1594 35 1.4 (0.8–2.5) 40 1.2 (0.7–2.1)
P 15 499 7 1.0 (0.4–2.6) 7 0.7 (0.3–1.9)
p-trend 1.00 p-trend 0.65
Alcohol from wine
No wine 3239 87 1.9 (1.1–3.1) 65 1.0 (0.6–1.7)
0.1–4 2679 69 1.5 (0.9–2.5) 72 1.2 (0.8–1.9)
5–14 1415 33 1.5 (0.8–2.7) 32 1.0 (0.6–1.9)
15–29 575 11 1.4 (0.6–3.1) 14 1.2 (0.6–2.5)
P 30 135 8 4.6 (1.6–13.4) 8 2.9 (1.0–8.5)
p-trend 0.38 p-trend 0.25
Alcohol from liquor
No liquor 2597 57 1.5 (0.9–2.5) 58 1.1 (0.7–1.7)
0.1–4 2208 63 1.7 (1.1–2.8) 58 1.2 (0.7–1.9)
5–14 1589 41 1.6 (0.9–2.8) 35 0.9 (0.5–1.6)
15–29 1130 33 1.8 (0.9–3.4) 25 0.9 (0.5–1.7)
P 30 518 14 2.0 (0.8–5.3) 15 1.2 (0.5–3.0)
p-trend 0.08 p-trend 0.78
Alcohol from red wine
No red wine 5030 127 1.6 (1.0–2.5) 116 1.1 (0.7–1.8)
0.1–4 2178 60 1.6 (0.9–2.7) 46 0.9 (0.5–1.5)
5–14 596 16 1.6 (0.8–3.4) 24 1.7 (0.9–3.3)
P 15 239 5 1.2 (0.4–3.7) 5 0.8 (0.3–2.5)
p-trend 0.32 p-trend 0.70
Alcohol from white/fortified wine
No white/fortified wine 4210 107 1.7 (1.1–2.8) 87 1.0 (0.7–1.7)
0.1–4 2804 70 1.5 (0.9–2.4) 73 1.1 (0.7–1.8)
5–14 785 19 1.6 (0.8–3.2) 20 1.2 (0.6–2.3)
P 15 243 12 3.6 (1.5–8.4) 11 2.2 (1.0–5.2)
p-trend 0.06 p-trend 0.12
1 Adjusted for age, family history of prostate cancer, socioeconomic status, and total alcohol intake.
2 Reference category.
3 Not adjusted for total alcohol intake.
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essentially. Certainly, confounding by unmeasured or
other unknown factors cannot be excluded.
In the majority of cohort [6–10, 12, 15–19] and case–
control studies [20, 23, 24, 27, 29–31, 33–35, 37, 39, 41,
42] no association between total alcohol consumption
and prostate cancer risk was found, and this was
confirmed in the NLCS. In one cohort study in Japan,
alcohol consumption was positively associated with
prostate cancer risk and when specific alcoholic bever-
ages were investigated, a significant positive association
for consumption of shochu was noted [14]. In another
cohort study alcohol abusers developed prostate cancer
more often than expected [11]. In none of the cohort
studies was a decreased risk observed. In case–control
studies a few positive associations [21, 25, 26], as well as
one inverse association [22] between total alcohol
consumption and prostate cancer risk, were noted.
Although a nonsignificant decreased riskwas suggested
in the highest intake category of beer in our study, in the
other exposure categories no association was found.
Other cohort [6, 10, 13, 14] and case–control studies [25,
27, 33, 36, 38, 41] support a conclusion of no association
between consumption of beer and risk of prostate cancer.
There was one cohort study in which ex-users of beer
showed an increased risk of prostate cancermortality [13].
In three case–control studies, beer consumption increased
prostate cancer risk [21, 26, 40] and in two of these studies
also a significant trend in risk was reported [21, 26].
However, in one of these case–control studies other types
of alcohol were also associated with an increased prostate
cancer risk and therefore it was concluded that the
association was due to alcohol and not due to some
components of specific types of beverages [21].
No association was found between red wine and
prostate cancer risk within the NLCS, but for consump-
tion of white wine and fortified wines increased risks
were observed at high intakes. Only in two other cohort
studies was wine consumption evaluated, and no asso-
ciations were noted [6, 10]. Also in most case–control
studies no associations were found [21, 25, 27, 32, 33, 38,
41], although some positive [26, 40] and inverse associ-
ations [36] were indicated. Men consuming daily white
wine or fortified wines might be a quite distinctive
socioeconomic group of the highest level. Therefore,
residual confounding by socioeconomic status or other
factors related to socioeconomic status might be an
explanation for our observed associations regarding
alcohol intake from white wine and fortified wines. This
explanation is further supported by the fact that, for
intake of alcohol from beer, an inverse association was
observed in the highest exposure category. Among older
subjects, high intake of beer was more common in the
lower than in the higher socioeconomic classes.
Consumption of liquor was, as in the NLCS, not
associated with prostate cancer risk in most other
epidemiological studies [6, 10, 13, 26–28, 33, 38, 40,
41]. Nevertheless, in three case–control studies a positive
association was observed [21, 25, 36] and there was a
significant trend in risk in one of these studies [21].
The biological pathway relating alcohol consumption
to prostate cancer risk is largely unknown, but some
mechanisms have been proposed to both explain an
inverse as well as a positive association between alcohol
consumption and prostate cancer risk. A decreased risk
has been explained by the fact that ethanol has been
found to decrease plasma testosterone levels [56], which
might decrease prostate cancer risk [25, 26]. An in-
creased risk of prostate cancer associated with alcohol
consumption has been explained by metabolic activation
of environmental nitrosamines by ethanol [21, 26].
Furthermore, alcohol contains contaminants that may
be carcinogenic and the major metabolite of alcohol,
acetaldehyde, is also known to be carcinogenic and
teratogenic [21]. Immunodepression might also be a
pathway through which tumor growth is stimulated by
consumption of alcohol [57]. Indirect eects of alcohol
consumption on prostate cancer risk could be nutrient
displacement, malabsorption, liver eects and related
pathology [21, 57]. A specific hypothesis concerning beer
consumption that has been proposed is that the nitros-
amine content of the beer in the past might be
responsible for an increased risk of prostate cancer
[26]. Finally, the observed positive associations of high
white wine and fortified wine consumption with prostate
cancer risk may be due to other unknown potential
biological pathways (e.g. non-alcoholic constituents),
or due to bias or confounding.
The hypothesis that environmental factors (alcohol
consumption) are more strongly related to advanced
prostate tumors was not confirmed in this investigation.
On the contrary, for dierent types of alcoholic bever-
ages, observed associations were most pronounced in
the subgroup of localized prostate tumors. The stronger
associations with localized rather than advanced pros-
tate cancer might suggest a social class eect related to
increased use of medical services among men with a
higher socioeconomic status. However, this issue was
separately investigated in the NLCS and no evidence for
this explanation was found (submitted for publication).
Results from other studies are also somewhat inconsis-
tent and do not uniformly point into a direction of
stronger associations with advanced prostate tumors
[21, 25, 27].
In summary, although total alcohol consumption
seems not to be related to prostate cancer risk, a
positive eect of high intakes of specific types of
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alcoholic beverages, i.e. white wine and fortified wines,
cannot be excluded. Thus far, however, data from
epidemiological studies on these types of wine are
sparse. Also, because a possible biological pathway by
which the observed eect can be explained is unknown,
this topic deserves further investigation.
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